[Open trial on the tolerance to Rhinaaxia in allergic rhinitis].
Forty-four patients, most of them with strong symptoms, were included in this study of the tolerance and efficacy of Rhinaaxia in the treatment of allergic rhinitis. Thirty two patients had good or very good tolerance. Others reported nasal irritation and sneezes after the sprays and one left the study for this reason. The efficacy on nasal symptoms is also very clear. On the third day of treatment the decrease of the nasal trouble was already significant.
Sabbah
A
A
Laboratoire d'Immuno-allergologie, C.H.U., Angers.
Bonneau
J C
JC
D000336:Aerosols; D004151:Dipeptides / Q000008:administration & dosage / Q000627:therapeutic use*; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D008297:Male; D012221:Rhinitis, Allergic, Perennial / Q000188:drug therapy*; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy*
D000336:Aerosols; D004151:Dipeptides; C027172:isospaglumic acid
Essai ouvert sur la tolérance du Rhinaaxia dans la rhinite allergique.